Question: Example(question='There has been an outbreak of an viral infectious disease in your city. You have been asked to design a molecular diagnostic kit for quick detection of this retrovirus. How would you go about designing this kit?', choice1='First you identify the virus by performing DNA sequencing. You then develop a PCR kit for  quick and accurate diagnosis', choice2='First you identify the IgG antibodies for the infection. You then develop an ELISA kit targeting IgG antibodies for quick \n and accurate diagnosis.', choice3='First you identify the virus using the information about the symptoms, provided by the affected patients. You then design a nested PCR kit based on the information for quick diagnosis.', choice4='First you identify the virus by performing cDNA sequencing.  You then develop a real time PCR kit for quick and accurate diagnosis.', correct_index=4)
Iteration: Test New Architecture_156
proposed answer: The optimal diagnostic approach for a retrovirus outbreak is to first identify the virus by performing cDNA sequencing, followed by developing a real-time PCR (qPCR) kit for rapid and accurate detection. Retroviruses have RNA genomes, so direct DNA sequencing is not feasible initially; the viral RNA must be reverse transcribed into complementary DNA (cDNA) before PCR amplification. Real-time PCR offers several advantages: it is rapid, highly sensitive and specific, allows quantification of viral load, and reduces contamination risk by eliminating post-PCR processing steps. Antibody-based methods like ELISA detect host immune responses that develop days to weeks after infection, making them unsuitable for early detection during an outbreak. Nested PCR, while sensitive, involves multiple amplification steps, increasing contamination risk and turnaround time, which is suboptimal for rapid diagnosis. The practical kit design should include: (1) sample collection materials (e.g., swabs, blood collection tubes), (2) RNA extraction reagents and kits to isolate viral RNA from patient samples, (3) reverse transcriptase enzyme and reagents to convert RNA into cDNA, (4) specific primers and fluorescent probes designed based on the cDNA sequence of the virus, (5) PCR reagents optimized for real-time amplification, (6) a portable real-time PCR machine or compatible platform for rapid thermal cycling and fluorescence detection, and (7) positive and negative controls to validate assay accuracy. The workflow involves collecting patient samples, extracting viral RNA, reverse transcribing RNA into cDNA, performing real-time PCR amplification with specific primers and probes, and analyzing fluorescence signals to detect and quantify viral presence. This approach ensures early, sensitive, and specific detection, enabling timely clinical and public health responses. It also overcomes limitations of antibody-based and nested PCR methods, making it the most effective strategy for rapid deployment in outbreak settings.

Answer:D)
Extracted answer: D)
Correct answer: 4
